Sickle Cell Gene Therapy Uptake May Lag, But Still Shock State Medicaid Budgets

 
• By Sarah Karlin-Smith
3d render of exponential red arrow pointing upwards
State Medicaid programs will face exponential new costs for sickle cell patients with new gene therapies • Source: Shutterstock

More from Market Access

More from Pink Sheet